Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scheduled Versus Treatment Administration of VSTs for Viral Infections After Allogeneic Stem Cell Transplant
NCT04230356Phase 2Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2021
- Primary completion
- Mar 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of viral-specific T-cells in viral infection (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Number of Treatment Failures. Started Jan 2021; status: recruiting.
02
Drugs
viral-specific T-cells
03
Conditions
viral infection
Beyond the preview
Go deeper on NCT04230356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04230356.